EFEarnings Feed

R

Company dossier

rEVO Biologics, Inc.

CIK 0000904973SIC 2836Biological Products, (No Diagnostic Substances)

Add to watchlist

Exchange

—

Entity type

operating

Fiscal year end

Dec 31

Headquarters

MA

SEC profile ↗

Recent filings

Latest submissions

7 items

8-KAccepted Dec 8, 7:00 PM ETAcc 0000912057-99-008791
GENZYME TRANSGENICS CORP4.6 KB
GENZYME TRANSGENICS CORP 8-K
View filing
10-QAccepted Nov 16, 7:00 PM ETAcc 0000912057-99-006652
GENZYME TRANSGENICS CORP60.1 KB
GENZYME TRANSGENICS CORP 10-Q
View filing
10-QAccepted Aug 17, 8:00 PM ETAcc 0001047469-99-032967
GENZYME TRANSGENICS CORP269.0 KB
GENZYME TRANSGENICS CORP 10-Q
View filing
10-QAccepted May 18, 8:00 PM ETAcc 0001047469-99-021505
GENZYME TRANSGENICS CORP53.4 KB
GENZYME TRANSGENICS CORP 10-Q
View filing
10-KAccepted Apr 4, 8:00 PM ETAcc 0001047469-99-013605
GENZYME TRANSGENICS CORP576.0 KB
GENZYME TRANSGENICS CORP 10-K
View filing
10-QAccepted Nov 11, 7:00 PM ETAcc 0001047469-98-040260
GENZYME TRANSGENICS CORP71.6 KB
GENZYME TRANSGENICS CORP 10-Q
View filing
10-QAccepted Aug 10, 8:00 PM ETAcc 0001047469-98-030313
GENZYME TRANSGENICS CORP96.1 KB
GENZYME TRANSGENICS CORP 10-Q
View filing

Monitoring

Insider owner filings: No
Insider issuer filings: Yes
Tickers on record: 0

Ticker roster

No tickers on record.

Addresses

business
175 CROSSING BLVD
FRAMINGHAM, MA, 01701
mailing
175 CROSSING BLVD
FRAMINGHAM, MA, 01701

Former names

GTC BIOTHERAPEUTICS INC
2002-06-03 – 2010-12-15
GENZYME TRANSGENICS CORP
1996-06-12 – 2002-04-18